Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 159-163, April 2007

Jon Van Rood: Pioneer at the Crossroad of Human Leukocyte Antigens and Transplantation

  • Jan Jansen

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jan Jansen, MD, PhD, Indiana Blood and Marrow Transplantation, Beech Grove, IN 46205.

Jon Van Rood (born in 1926) has made major contributions to the fields of transfusion medicine as well as organ and stem cell transplantation. His group was the first to start unraveling the complexity of the human leukocyte antigen (HLA) system through collaborative studies that used panels of sera and leukocyte samples. Furthermore, using HLA typing, he introduced the first HLA-matched platelet transfusions and developed routine leukocyte depletion as a means to prevent HLA alloimmunization. Van Rood has also been active in the fields of kidney transplantation (Eurotransplant) and stem cell transplantation (Europdonor). He combined scientific laboratory research with application to clinical medicine. He retired from his university position in 1991 but remains active in the field.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-7963(06)00097-6

doi:10.1016/j.tmrv.2006.11.006

Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 159-163, April 2007